Psilocybin, the active compound in magic mushrooms, is showing promise in phase 2 clinical trials for the treatment of treatment-resistant depression and PTSD.

Authors

• Person: Not available Organization: Springer
  Medicinal plants and human health: a comprehensive review of ...

Sources

• Medicinal plants and human health: a comprehensive review of ... link.springer.com Springer via serper

Referenced by nodes (4)

• psilocybin concept
• depression concept
• psilocybin mushrooms concept
• PTSD concept